Analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target of $61.00. Pick the best stocks and maximize your ...

2024--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) announced results from 18 presentations reinforcing its leadership in cell therapy, with data demonstrating efficacy, durability and safety ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 ...

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO). The company is looking to consolidate its older drug, Nuplazid, while boosting ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Carcone scored a goal on two shots and went plus-2 in Sunday's 4-2 win over the Flyers. Carcone has two goals and an assist over his last four contests. The 28-year-old remains in a fourth-line ...

Former Stanley Cup champion Kevin Shattenkirk officially announced his retirement from the NHL after 14 seasons between the ...

In each of the past three seasons, the Methuen High boys’ hockey team has not only won a combined 41 games, increasing win ...

Lauded filmmaker Michael Mann gave a special presentation on his “Michael Mann’s Ferrari Expanded” website at the Red Sea International Film Festival, where he walked the audience through ...

Bristol-Myers Squibb Co. plotted to rip off investors in a 2016 acquisition through legal gamesmanship aimed at evading a $450 million payment, according to a lawsuit unsealed Tuesday. The ...